(2023). Real-world study of the concomitant use of biphasic insulin as part 30/70 with GLP-1 receptor agonist versus first-generation basal insulin with GLP-1 receptor agonist in type 2 diabetes. Diabet Med, e15267. http://doi.org/10.1111/dme.15267
. A. Jensen
First name
A.
Middle name
B.
Last name
Jensen
(2023). Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal-bolus insulin in UK clinical practice. Diabetes Obes Metab. http://doi.org/10.1111/dom.15278
. (2023). Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.15165
.